Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 1456 results found. Search for [ pharmaceutical companies ]

Results 1100 to 1120 of 1456
New Delhi, March 31, 2014
While pharmaceutical industry is anticipated to get salary hike of 14-15 per cent, that in automobile segment is likely to 13-14 per cent. Real estate sector is projected to register 12-14 per cent increase in pay packets.

Mahesh Nayak
March 31, 2014
The mood of the market may have turned positive, but the fear of losing money still remains fresh in the minds of the public, thus keeping many waiting at the sidelines. Though one should keep room for safety, it's time to invest in the Indian equity market.

Bill Berkrot
New York, March 26, 2014
Analysts say in the short term, the recent troubles are expected to benefit larger global competitors, such as Teva Pharmaceutical Industries, Actavis Plc and Mylan Inc, which will be called upon to supply drugs no longer available from some of their rivals in India.

Mail Today Bureau
New Delhi, March 24, 2014
Commerce and industry minister Anand Sharma on Sunday came out strongly to defend India's track record on intellectual property rights and said that the country is ready to take on the US at the World Trade Organization (WTO) over the issue.

Toni Clarke and Bill Berkrot
Washington/New York, March 19, 2014
India supplies about 40 per cent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.

Sumeet Chatterjee and Ben Hirschler
Mumbai/London, March 12, 2014
Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States.
March 13, 2014
Events that made news this fortnight -

New Delhi, March 10, 2014
\"87 developing nations, their entire health care system is supported by Indian medicines, and we're committed to ensure that even the new generation of life-saving drugs, the Indian pharmaceutical industry will make, are available to our people and people of developing countries,\" Commerce Minister Anand Sharma said.
March 10, 2014
Business Today readers' feedback on the magazine's coverage -

Vikas Gupta
March 7, 2014
Stay away from FMCG, IT, pharma and private banks, says Vikas Gupta of Arthveda Fund Management.

Zeba Siddiqui, Sumeet Chatterjee and Ben Hirschler
Mumbai, March 6, 2014
Indian pharmaceutical firms are the world's biggest manufacturers of generics, but Lupin is the only Indian drugmaker that has so far made significant inroads in Japan.

Mumbai, February 25, 2014
Shares of the company opened on a weak note at Rs 364 and then plunged as much as 2.36 per cent to an early low of Rs 354.85 on the Bombay Stock Exchange.

Mumbai , February 25, 2014
Ranbaxy Laboratories has suspended all shipments of pharmaceutical ingredients produced at two local factories to review processes and controls. The Toansa and Dewas plants are currently banned from shipping products to the United States following quality concerns.

Josey Puliyenthuruthel
February 22, 2014
Whether the Gandhi scion or Modi listen or not, there's another quarter in India that has its ears full with the role of governments and regulations: Indian Pharma.

New Delhi, February 22, 2014
\"We are not targeting Indian companies. We are undertaking our required regulatory activities. We inspect and take appropriate action against companies within the United States,\" US Food and Drug Administration (FDA) Commissioner Margaret Hamburg  told reporters during a conference call.

E. Kumar Sharma
February 26, 2014
The US regulators increased scrutiny of Indian drug exporters is giving the pharmaceutical industry the jitters. Besides becoming more frequent, inspections are also more often unannounced. Adding to Indian drug makers anxiety is the nature and scope of the inspections.

New Delhi, February 19, 2014
The company's overall strategy is to focus on its remaining brands, including Eldervit and Somazina, and position itself further in the growing nutraceuticals segment by launching more products.

Karen Freifeld and Chris Peters
Bangalore/New York, February 19, 2014
Under the terms of the settlement, the two generic drug makers will end a 2010 agreement of not challenging each other's rights to sell certain drugs exclusively in the United States.

New Delhi, February 17, 2014
Pharmaceutical sales in India are expected to rise by 14.4 per cent to $27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, says a report.

E. Kumar Sharma
February 17, 2014
Margaret A Hamburg, US Food and Drug Administration (USFDA) Commissioner on her first official visit to India, has been visiting the Taj Mahal and also writing down her impressions of the meetings she has had in India. 

PAGES 56 OF 73  5657585960